NAMS
Price
$24.88
Change
+$0.25 (+1.02%)
Updated
Sep 3 closing price
Capitalization
2.8B
74 days until earnings call
QURE
Price
$17.38
Change
+$0.37 (+2.18%)
Updated
Sep 3 closing price
Capitalization
954.68M
55 days until earnings call
Interact to see
Advertisement

NAMS vs QURE

Header iconNAMS vs QURE Comparison
Open Charts NAMS vs QUREBanner chart's image
NewAmsterdam Pharma
Price$24.88
Change+$0.25 (+1.02%)
Volume$1.02M
Capitalization2.8B
uniQure
Price$17.38
Change+$0.37 (+2.18%)
Volume$1.48M
Capitalization954.68M
NAMS vs QURE Comparison Chart in %
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. QURE commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and QURE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NAMS: $24.63 vs. QURE: $17.01)
Brand notoriety: NAMS and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 66% vs. QURE: 113%
Market capitalization -- NAMS: $2.8B vs. QURE: $954.68M
NAMS [@Biotechnology] is valued at $2.8B. QURE’s [@Biotechnology] market capitalization is $954.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 5 bearish.
  • QURE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, QURE is a better buy in the short-term than NAMS.

Price Growth

NAMS (@Biotechnology) experienced а -2.22% price change this week, while QURE (@Biotechnology) price change was +7.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

QURE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($2.8B) has a higher market cap than QURE($955M). QURE YTD gains are higher at: -3.681 vs. NAMS (-4.163). QURE has higher annual earnings (EBITDA): -119.56M vs. NAMS (-237.93M). NAMS has more cash in the bank: 739M vs. QURE (377M). NAMS has less debt than QURE: NAMS (328K) vs QURE (66.7M). NAMS has higher revenues than QURE: NAMS (64M) vs QURE (14.3M).
NAMSQURENAMS / QURE
Capitalization2.8B955M293%
EBITDA-237.93M-119.56M199%
Gain YTD-4.163-3.681113%
P/E RatioN/AN/A-
Revenue64M14.3M448%
Total Cash739M377M196%
Total Debt328K66.7M0%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSQURE
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
70%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNRAX35.940.07
+0.20%
Franklin Natural Resources Adv
EQTKX16.24-0.06
-0.37%
Shelton Equity Income Class K
ICTTX15.28-0.07
-0.46%
ICON Health and Information Tech Inv
ALVSX11.25-0.06
-0.53%
American Century Focused Lg Cap Val I
APGCX63.97-0.47
-0.73%
AB Large Cap Growth C

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+2.41%
QURE - NAMS
56%
Loosely correlated
+4.16%
CRDF - NAMS
41%
Loosely correlated
-7.14%
IRON - NAMS
39%
Loosely correlated
+2.94%
BEAM - NAMS
39%
Loosely correlated
-0.31%
OCUL - NAMS
37%
Loosely correlated
+4.01%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NAMS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NAMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+4.16%
NAMS - QURE
57%
Loosely correlated
+2.41%
BEAM - QURE
48%
Loosely correlated
-0.31%
MGX - QURE
45%
Loosely correlated
+4.60%
ABSI - QURE
44%
Loosely correlated
-2.09%
ACLX - QURE
43%
Loosely correlated
+0.52%
More